|
|
40
|
|
|
41011
|
|
|
ZOMETA 4MG INJ (NVS/COL) ZOLENDRONIC ACID
|
|
|
ZOLENDRONIC ACID
|
|
|
ZOMETA
|
|
|
4MG VIAL
|
|
|
C
|
|
|
842.68
|
|
|
842.68
|
|
|
4MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
9224
|
|
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|